SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
鲤鱼豪
Lv6
1690 积分
2022-08-11 加入
最近求助
最近应助
互助留言
Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells
2个月前
已完结
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
2个月前
已完结
Extracellular targeted protein degradation: an emerging modality for drug discovery
3个月前
已完结
Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engager
5个月前
已完结
The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
5个月前
已完结
Antibody–drug conjugates for cancer score with ROR1
5个月前
已完结
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
6个月前
已完结
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
6个月前
已完结
ROR1 expression in mature B lymphoid neoplasms by flow cytometry
8个月前
已完结
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy
8个月前
已完结
没有进行任何应助
速度真快
2个月前
速度真快
3个月前
点赞
6个月前
感谢
6个月前
https://aacrjournals.org/cancerimmunolres/article-abstract/doi/10.1158/2326-6066.CIR-23-0638/741888/Engineering-CD3-CD137-dual-specificity-into-a-DLL3?redirectedFrom=fulltext 文章错误,是这篇链接
6个月前
么么哒
8个月前
速度真快
1年前
感谢
1年前
感谢
1年前
自己找到了【积分已退回】
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论